<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1999">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05135143</url>
  </required_header>
  <id_info>
    <org_study_id>22-63/3</org_study_id>
    <nct_id>NCT05135143</nct_id>
  </id_info>
  <brief_title>Role of Antioxidants in the Reduction of Oxidative Stress in Infertile Patients</brief_title>
  <acronym>OAT</acronym>
  <official_title>Role of Antioxidants in the Reduction of Oxidative Stress in Infertile Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Tetova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Tetova, Faculty of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Tetova</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Numerous studies verify that the majority of cases of male infertility belong to the group&#xD;
      diagnosed with oligoasthenoteratozoospermia (OAT), which means a decrease in the number of&#xD;
      sperm in the ejaculate to 15 million / ml, reduced sperm motility of the spermatozoa and&#xD;
      morphological disorders of the neck or tail of the sperm.&#xD;
&#xD;
      Genuine scientific studies can not pinpoint the cause of these changes, however, recent&#xD;
      advances in science shed light on this issue by confirming the reason, which is as a result&#xD;
      of the action of free radicals - oxidative stress.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The enlightenment project in the field of male infertility in North Macedonia will include a&#xD;
      wide team of: students, general practitioners, assistants, professors of pre-clinical&#xD;
      subjects, professors and specialists in the field of gynecology, urology and andrologists.&#xD;
      The involvement of such a large number of professionals once again verifies the seriousness&#xD;
      and determination that this scientific project has.&#xD;
&#xD;
      Investigators hope to contribute generously to:&#xD;
&#xD;
        1. Identifying new cases and taking measures early, in order to overcome fertilization&#xD;
           problems;&#xD;
&#xD;
        2. For the first time in North Macedonia there will be a more accurate picture of the&#xD;
           prevalence of male infertility;&#xD;
&#xD;
        3. Expanding current scientific knowledge about the role of oxidative stress, its&#xD;
           laboratory evaluation, and the impact of antioxidant supplements;&#xD;
&#xD;
        4. Standardization of doses and type of antioxidant supplements that will be used during&#xD;
           the realization of this dissertation and evaluation of their clinical effect in men with&#xD;
           OAT;&#xD;
&#xD;
        5. After the implementation of antioxidant therapy, investigators expect that the results&#xD;
           of live births and spontaneous pregnancies will increase, while the number of&#xD;
           miscarriages will decrease;&#xD;
&#xD;
        6. Acquisition of knowledge on laboratory and clinical evaluation techniques of infertile&#xD;
           men, which would later lead to the establishment of an andrological laboratory.&#xD;
           Investigators anticipate this laboratory to function within the Faculty of Medical&#xD;
           Sciences, where all procedures will be performed, from diagnosis to the operation of&#xD;
           assisted reproduction techniques (TRA). This, in addition to the material benefit for&#xD;
           the benefit of the University of Tetova, also has a benefit in terms of staff, which&#xD;
           will be professionalized and trained during the realization of this dissertation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Actual">January 31, 2021</completion_date>
  <primary_completion_date type="Actual">June 30, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Double blind randomized</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sperm parameters</measure>
    <time_frame>6 months</time_frame>
    <description>Concentration (10x6 ml)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sperm parameters</measure>
    <time_frame>6 months</time_frame>
    <description>Morphology (percentage)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sperm parameters</measure>
    <time_frame>6 months</time_frame>
    <description>Motility (percentage)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>oxidative stress parameters</measure>
    <time_frame>6 months</time_frame>
    <description>MDA (mg/ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxidative stress parameters</measure>
    <time_frame>6 months</time_frame>
    <description>Caspase 3 (IU/ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxidative stress parameters</measure>
    <time_frame>6 months</time_frame>
    <description>TAC (IU/ml)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">211</enrollment>
  <condition>Infertility</condition>
  <condition>Oligoasthenozoospermia</condition>
  <condition>Male</condition>
  <arm_group>
    <arm_group_label>Infertility male patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infertile male patients will receive the antioxidant formula for more than 172 days. Divided in two groups. One will take the active substance, to the other group placebo treatment will be given.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo treatment and control and comparative variables will be measured.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Antioxidant formula</intervention_name>
    <description>Administration of antioxidant formula 3 times a day and once daily.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Infertility male patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age, 19-45 years;&#xD;
&#xD;
          -  infertility, 2 years;&#xD;
&#xD;
          -  regular sexual intercourse with a fertile female.&#xD;
&#xD;
          -  The female partner was defined as being fertile if she had undergone a negative&#xD;
             infertility workup (biphasic basal body temperature, P evaluation in luteal phase,&#xD;
             ultrasound ovary and uterus evaluation, and hysterosalpingogram to study tubal&#xD;
             patency)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  use of antioxidant agents or vitamins within 8 weeks prior to inclusion in the study,&#xD;
&#xD;
          -  a history of excessive consumption of alcohol 40 days prior to the start of the trial,&#xD;
&#xD;
          -  patients that showed lower than 5% motility and less than 1 × 106/ml sperm&#xD;
             concentration, - patients with any acute or chronic disease or&#xD;
&#xD;
          -  who are undergoing some kind of treatment with any class of drugs and&#xD;
&#xD;
          -  subjects with known hypersensitivity to ingredients in the antioxidant formula.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Because investigators have to measure sperm parameters</gender_description>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vegim Zhaku, MD, PhDc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tetova</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sheqibe Beadini, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Tetova</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nexhbedin Beadini, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Univeristy of Tetova</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Univeristy of Tetova</name>
      <address>
        <city>Tetovo</city>
        <zip>6338</zip>
        <country>North Macedonia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>North Macedonia</country>
  </location_countries>
  <link>
    <url>https://www.intechopen.com/chapters/77097</url>
    <description>Male infertility, Oxidative Stress and Antioxidants</description>
  </link>
  <link>
    <url>https://eprints.unite.edu.mk/561/</url>
    <description>ROLE OF ANTIOXIDANTS IN THE DIMINUTION OF OXIDATIVE STRESS AND AMELIORATION OF SEMEN PARAMETERS IN IDIOPATHIC MALE INFERTILITY</description>
  </link>
  <link>
    <url>https://keypublishing.org/jhed/jhed-volumes/jhed-volume-26-fqs-3-vegim-zhaku-sheqibe-beadini-nexhbedin-beadini-besir-murtezan-2019-combination-of-maca-korean-ginseng-extract-and-antioxidant-therapy-for-male-with-oligoasthenozoos/</url>
    <description>COMBINATION OF MACA, KOREAN GINSENG EXTRACT AND ANTIOXIDANT THERAPY FOR MALE WITH OLIGOASTHENOZOOSPERMIA: CASE STUDY</description>
  </link>
  <link>
    <url>https://www.endocrine-abstracts.org/ea/0070/ea0070ep581</url>
    <description>Oral antioxidants improve sperm motility, sperm concentration and reduce oxidative stress in males with oligoasthenozoospermia</description>
  </link>
  <reference>
    <citation>Vegim Zhaku, Ashok Agarwal, Sheqibe Beadini, Ralf Henkel, Renata Finelli, Nexhbedin Beadini and Sava Micic (June 8th 2021). Male Infertility, Oxidative Stress and Antioxidants, Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects, Pınar Erkekoglu and Júlia Scherer Santos, IntechOpen, DOI: 10.5772/intechopen.98204. Available from: https://www.intechopen.com/chapters/77097</citation>
  </reference>
  <reference>
    <citation>] Zhaku V, Beadini Sh, Beadini N, Xhaferi V, Golaboska J. The role of semen analysis in the expression of male infertility in southwestern part of North Macedonia (Experiences from 7 municipalities). UNIVERSI-International Journal of Education Science Technology Innovation Health and Enviroment. 2019;5(2):96-104.</citation>
  </reference>
  <reference>
    <citation>Zhaku V, Beadini Sh, Beadini N, Murtezani B. Combination of Maca, Korean ginseng extract and antioxidant therapy for male with oligoasthenozoospermia: case study. Journal of Hygienic Engineering and Design. 2019; 26(1):28-35.</citation>
  </reference>
  <reference>
    <citation>Zhaku V, Beadini Sh, Beadini N, Xhaferi V. Role of antioxidants in the diminution of oxidative stress and amelioration of semen parameters in idiopathic male infertility. Acta Medica Balkanica. 2020; 5(9-10):69-80.</citation>
  </reference>
  <reference>
    <citation>Zhaku V, Beadini Sh, Beadini N, Xhaferi V, Milenkovic T. Oral antioxidants improve sperm motility, sperm concentration and reduce oxidative stress in males with oligo-asthenozoospermia. In: 22nd European Congress of Endocrinology; 5-9 September 2020; Prague, Czech Republic: Endocrine Abstracts (2020) 70 EP581. DOI:10.1530/ endoabs.70.EP581</citation>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 25, 2021</study_first_submitted>
  <study_first_submitted_qc>November 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2021</study_first_posted>
  <last_update_submitted>November 27, 2021</last_update_submitted>
  <last_update_submitted_qc>November 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Tetova</investigator_affiliation>
    <investigator_full_name>Vegim Zhaku</investigator_full_name>
    <investigator_title>Medical Doctor and Teaching assistant</investigator_title>
  </responsible_party>
  <keyword>antioxidant</keyword>
  <keyword>oxidative stress</keyword>
  <keyword>sperm parameters</keyword>
  <keyword>Malonedialdehyde</keyword>
  <keyword>total antioxidant capacity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Sperm parameters before and after treatment. OS parameters before and after treatment.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

